We are pleased to announce the publication of a new study ⧉ highlighting the effectiveness of DaraEx in overcoming interference caused by mezagitamab during serological pre-transfusion testing.
A recent publication details the use of imusyn's IVD DaraEx plus to mitigate the interference of anti-CD38 antibodies in the IAT ⧉.
DaraEx plus is available from inno-train ⧉.
New versions of the IFU for rBGA are now available (release 2025/05).
EN ISO 13485:2016, issued May 09th, 2023
Certificate Directive 98/79/EC, issued May 20th, 2022
![]() | General Terms and Conditions of Business (AGB) |